Coronary heart disease (CHD) - One or several diseases? Changes in the prevalence and features of CHD

Perspectives in Biology and Medicine

Volumn 50, Issue 2, 2007, Pages 227-242

  Azambuja, Maria Inês ^a   Levins, Richard ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR;

AUTOIMMUNE DISEASE; CHRONIC DISEASE; CORONARY ARTERY THROMBOSIS; DEGENERATIVE DISEASE; DISEASE PREDISPOSITION; EMPIRICAL RESEARCH; EMPIRICISM; HISTORY; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MORTALITY; PANDEMIC; PATHOGENESIS; PATHOPHYSIOLOGY; PERSONAL EXPERIENCE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; ARTICLE; CORONARY ARTERY DISEASE; EPIDEMIC; EPIDEMIOLOGY; HYPERLIPIDEMIA; INFLUENZA; RISK FACTOR; THROMBOSIS;

CAUSALITY; CHRONIC DISEASE; CORONARY DISEASE; DISEASE OUTBREAKS; HISTORY, 20TH CENTURY; HUMANS; HYPERLIPIDEMIAS; INFLUENZA, HUMAN; INSULIN RESISTANCE; PREVALENCE; RISK FACTORS; THROMBOSIS;

EID: 34248165942     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: 10.1353/pbm.2007.0013     Document Type: Review

References (81)

1. Alling, D. W., W. C. Blackwelder, and C. H. Stuart-Harris. 1981. A study of excess mortality during influenza epidemics in the United States, 1968-1976. Am J Epidemiol 113:30-43.
2. Armstrong G. L., L. A. Conn, and R. W. Pinner. 1999. Trends in infectious disease mortality in the United States during the 20th century. JAMA 281:61-66.
3. Azambuja, M. I. R. 1998. 1918 influenza pandemic and the rise in CHD mortality: Cause and effect? Poster presented at the International symposium on infection and atherosclerosis, Veyrier-du-Lac, France. http://infodoc.inserm.fr/ athero/Athero.nsf/397fe8563d75f39bc12563f60028ec43/ 3136629c654ee302802566780033cfac.
4. Azambuja, M. I. 2004. Spanish flu and early 20th-century expansion of a coronary heart disease-prone sub-population. Tex Heart Inst J 31:14-21. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid= 15061621#r3-4#r3-4.
5. Azambuja, M. I., and B. B. Duncan. 2002. Similarities in mortality patterns from influenza in the first half of the 20th century and the rise and fall of ischemic heart disease in the United States: A new hypothesis concerning the coronary heart disease epidemic. Cad. Saúde Pública 18(3):557-577. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102- 311X2002000300002&lng=en&nrm=iso.
6. Barker, D. J. 2005. The developmental origins of insulin resistance. Horm Res 64(S3):S2-S7.
7. Barker, D. J., et al. 1989. Weight in infancy and death from ischaemic heart disease. Lancet 2:577-80.
8. Campbell, M. 1963. Death rates from diseases of the heart: 1876-1959. BMJ 5356:528-35.
9. Capron, L. 1993. Mechanisms inflammatoires de l'athérosclerose: Inferences pathogéniques et étiologiques. Arch Mal Coer 86:19-30.
10. Carroll, M. D., et al. 2005. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 294:1773-81.
11. Collins, S. D. 1932. Excess mortality from causes other than influenza and pneumonia during influenza epidemics. Pub Health Reports 47:2159-79.
12. Cunningham, M. J., and R. C. Pasternack. 1988. The potential role of viruses in the pathogenesis of atherosclerosis. Editorial. Circulation 77:964-66.
13. De Cross, A. J., and B. J. Marshall. 1993. The role of helicobacter pylori in acid-peptic disease. Am J Med Sci 306:381-92.
14. De Geest, B. R., S. A. Van Linthout, and D. Collen. 2003. Humoral immune response in mice against circulating induced by adenoviral transfer is strictly dependent on expression in antigen-presenting cells. Blood 101:2551-56.
15. Drake, A. J., and B. R. Walker. 2004. The intergenerational effects of fetal programming: Non-genomic mechanisms for the inheritance of low birth weight and cardiovascular risk. J Endocrinol 180:1-16.
16. Eickoff, T. C., I. L. Sherman, and R. E. Serfling. 1961. Observations on excess mortality associated with epidemic influenza. JAMA 176:776-82.
17. Elveback, L. R. 1979. Coronary heart disease in Rochester, Minn., 1950-75: Incidence and survivorship. In: Proceedings of the Conference on the Decline in Coronary Heart Disease Mortality, 1978, ed. M. Feinleib, R. J. Havlick, and T. Thom, 116-23. Bethesda: U.S. Dept. of Health, Education and Welfare, PHS, NIH publ. no. 79-1610.
18. Evans, A. S. 1982. Viruses. In Cancer epidemiology and prevention, ed. D. Schottenfeld and J. F. Fraumeni Jr., 364-90. Philadelphia: W. B. Saunders.
19. Fabricant, C. G., et al. 1981. Herpes infection enhances cholesterol and cholesteryl ester accumulation in cultured arterial smooth muscle cells. Am J Pathol 105:176-83.
20. Fleck, L. 1935. Genesis and development of a scientific fact. Chicago: Univ. of Chicago Press, 1979.
21. Fruchart, J. C., et al. 2004. New risk factors for atherosclerosis and patient risk assessment. Circulation 109:III-15-III-19. http://circ.ahajournals.org/cgi/content/full/109/23_suppl_1/III-15.
22. Goldstein, J. L., et al. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low-density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76:333-37.
23. Gordon, T., and T. Thom. 1975. The recent decrease in CHD mortality. Prev Med 4:115-25.
24. Gould, S. J. 1996. Full house: The spread of excellence from Plato to Darwin. New York: Harmony Books.
25. Gurevich, V.S., V. M. Pleskov, and M. V. Levaya. 2005. Autoimmune nature of influenza atherogenicity. Ann NY Acad Sci 1050:410-16.
26. Hajjar, D. P., et al. 1987. Herpes simplex virus infection in human arterial cells: Implications in arteriosclerosis. J Clin Inv 80:1317-21.
27. Havlick, R. J., and M. Feinleib, eds. 1979. Proceedings of the Conference on the Decline in Coronary Heart Disease Mortality, 1978. Bethesda: U.S. Department of Health, Education and Welfare, PHS, NIH publn. no. 79-1610.
28. Houseworth, J., and A. D. Langmuir. 1974. Excess mortality from epidemic influenza, 1957-1966. Am J Epidemiol 100:40-48.
29. Javier Nieto, F. 1998. Infections and atherosclerosis: New clues from an old hypothesis. Am J Epidemiol 148:937-48.
30. Jousilahti, P., et al. 1996. Twenty-year dynamics of serum cholesterol levels in the middle-aged population of eastern Finland. Ann Int Med 125:713-22.
31. Kahn, H. A., and T. R. Dawbner. 1966. The development of coronary heart disease in relation to sequential biennial measures of cholesterol in the Framingham study. J Chron Dis 19:611-20.
32. Kattainen, A., et al. 2006. Coronary heart disease: From a disease of middle-aged men in the late 1970s to a disease of elderly women in the 2000s. Eur Heart J 27:296-301.
33. Kerjaschki, D., et al. 1997. Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis. J Clin Invest 100:2303-9.
34. Keys, A., et al. 1963. Coronary heart disease among Minnesota business and professional men followed fifteen years. Circulation 28:381-95.
35. Kuller, L. H. 1987. Relationship between acute and chronic disease epidemiology. Yale J Biol Med 60:363-76.
36. Lawlor, D. A., et al. 2002. Secular trends in mortality by stroke subtype in the 20th century: A retrospective analysis. Lancet 360(9348):1818-23.
37. Levins, R., and R. C. Lewontin. 1985. The dialectical biologist. Cambridge: Harvard Univ. Press.
38. Levy, R. I. 1981. The decline in cardiovascular diseases mortality. Ann Rev Public Health 2:49-70.
39. Lewontin, R. 2001. The triple helix: Gene, organism and environment. Cambridge: Harvard Univ. Press.
40. Libby, P., P. M. Ridker, and A. Maseri. 2002. Inflammation and atherosclerosis. Circulation 105:1135-43.
41. Lorber, B. 1996. Are all diseases infectious? Ann Int Med 125:844-51.
42. Madjid, M., et al. 2004. Influenza and cardiovascular diseases. Is there a causal relationship? Tex Heart Inst J 31:4-13.
43. Marmot, M. 1976. Facts, opinions and affaires du coeur. Am J Epidemiol 103:519-26.
44. McKinley, J. B., S. M. McKinley, and R. A. Beaglehole. 1989. A review of the evidence concerning the impact of medical measures on recent mortality and morbidity in the United States. Int J Health Serv 19:181-208.
45. Meade, T. W. 1992. Atheroma and thrombosis in cardiovascular disease: Separate or complementary? In Coronary heart disease epidemiology: From etiology to public health, ed. M. Marmot and P. Elliott, 287-97. Oxford: Oxford Medical Publications.
46. Meaney, M. J. 2001. Nature, nurture and the disunity of knowledge. Ann NY Acad Sci 935:50-61.
47. Metha, J. L., X. G. P. Saldeen, and K. R. Rand. 1998. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary heart disease. J Am Coll Cardiol 31:1217-25.
48. Metchnikoff, E. 1910. The prolongation of life: Optimistic studies. New York: Putnam.
49. Morris, J. N. 1951. Recent history of coronary disease. Lancet 1:1-7, 69-73.
50. Morris, J. N. 1964. Uses of epidemiology. Edinburgh: Livingstone.
51. National Heart, Lung and Blood Institute (NHLBI). 2002. Morbidity and mortality: Chartbook on cardiovascular, lung and blood diseases. Rockville, MD: U.S. Department of Health and Human Services, NIH.
52. Njenga, M. K., and C. A. Dangler. 1996. Intimal lipid accretion and elevated serum cholesterol in Marek's disease virus-inoculated chickens. Vet Pathol 33:704-8.
53. Osler, W. 1908. Diseases of the arteries. In Modern medicine: Its theory and practice in original contributions by American and foreign authors, ed. W. Osler and T. McCrae, 4:426-47. Philadelphia: Lea and Febiger. Cited in F. Javier Nieto (1998).
54. Pasternak, R. C., et al. 2003. 34th Bethesda Conference, Task Force 1. Identification of coronary heart disease risk: Is there a detection gap? J Am Coll Cardiol 41:1863-74.
55. Pearce, N. 1996. Traditional epidemiology, modern epidemiology and public health. Am J Public Health 86:678-83.
56. Pepine, C. I. 1997. Changing myocardial infarction population characteristics: Reasons and implications. Am Heart J 134(2 pt. 2):S1-S4.
57. Pleskov, V. M., A. I. Bannikov, and I. V. Zaitzev. 1994. [The receptor-mediated endocytosis of influenza viruses and low-density lipoproteins by tissue cells]. Vopr Virusol 39: 121-25. [Russian].
58. Reinert-Azambuja, M. I. 1994. Influenza pandemic and ischemic heart disease epidemic: Cause and effect? 10th International Symposium on Atherosclerosis, Montreal, 1994. Atherosclerosis 109:328 [abstract].
59. Ridker, P. M., et al. 2002. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347: 1557-65.
60. Rosamund, W. D., et al. 1998. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 339:861-67.
61. Rose, G. 1985. Sick individuals and sick populations. Int J Epidemiol 14:32-38.
62. Rosen, M. R. 2002. Blunderbuss to Mickey Mouse: The evolution of antiarrytmic targets. Circulation 106:1180-82.
63. Ross, R., and J. A. Glomset. 1976. The pathogenesis of atherosclerosis. N Engl J Med 296: 369-77, 420-25.
64. Rothman, K. J. 1982. Modern epidemiology. Boston: Little, Brown.
65. Rothman, K. J., and S. Greenland. 2005. Causation and causal inference in epidemiology. Am J Public Health S1:144-50.
66. Sheth, T., et al. 1999. Increased winter mortality from acute myocardial infarction and stroke: The effect of age. JAAC 33:1916-19.
67. Spain, D. M. 1960. Problems in the study of coronary atherosclerosis in population groups. J NY Acad Sci 84:816-34.
68. Stallones, R. A. 1980a. The rise and fall in ischemic heart disease mortality. Sci Am 243: 43-49.
69. Stallones, R. A. 1980b. To advance epidemiology. Ann Rev Public Health 1:69-82.
70. Stehbens, W. 1992. Causality in medical science with particular reference to heart disease and atherosclerosis. Perspect Biol Med 36(1):97-119.
71. Stehbens, W. 1993. The quality of epidemiologic data in coronary heart disease and atherosclerosis. J Clin Epidemiol 46:1337-46.
72. Steinberg, D. 1970. Progress, prospects and provender. Circulation 41:723-28.
73. Steinberg, D., and J. L. Witztum. 1990. Lipoproteins and atherogenesis: Current concepts. JAMA 264:3047-52.
74. Susser, M., and E. Susser. 1996. Choosing a future for epidemiology. II. From black box to Chinese boxes and eco-epidemiology. Am J Public Health 86:674-77.
75. Tauber, A. I. 1994. The immune self: Theory or metaphor? Immunol Today 15:134-36.
76. Tauber, A. I. 1997. The immune self: Theory or metaphor? Cambridge: Cambridge Univ. Press.
77. Taubes, G. 2001. The soft science of dietary fat. Science 291:2536-45.
78. Thorn, T. J. 1989. International mortality from heart disease: Rates and trends. Int J Epidemiol 18:S20-S28.
79. Virchow, R. 1858. Cellular pathology: As based upon physiological and pathological histology. Lecture XVI. Atheromatous affection of arteries. Repr. in Nutr Rev 47:23-25, 1989.
80. Wick, G., et al. 1995. Is atherosclerosis an immunologically mediated disease? Immunol Today 16:27-33.
81. Wucherpfennig, K. W., and J. L. Strominger. 1995. Molecular mimicry in T-cell mediated auto-immunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695-705.